Antibiotic shortages are worsening global infection treatment, forcing doctors to use toxic last-resort drugs and accelerating resistance. With 42% more shortages than other medications, this crisis threatens millions-especially in low-resource areas.
Drug shortages are a growing crisis tied to fragile global supply chains. Learn how pharmaceutical companies and governments are building resilience through diversified sourcing, AI forecasting, buffer stocks, and new manufacturing tech to prevent life-threatening gaps in medicine availability.